A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...

How are UC Davis scientists educating the public about the important research conducted on their campus? And how can outreach ...

ISTE+ASCD announced a $1 million grant from Pinterest to help school leaders create healthy digital cultures. The initiative ...

Debiopharm announces oral and poster presentations on data from their potential first-in-class compound Debio 1562M, a CD37-targeted ADC, and their best-in-class compound Debio 0123, a brain-penetrant ...

This Earth Day, sustainability editor Juliet Kinsman shares her favorite voluntourism opportunities around the world—from ...

In a wide-ranging Genomic Press Interview, Dr. Jeremie Poschmann of INSERM and Université de Nantes shares the story behind ...

As a program director, I have found some residents eager to attend professional conferences while others tend to shy away ...

In what serves as an experiential learning opportunity, students in Patrick Fennell’s Marketing Research class at Kennesaw ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...

April 2025 – CK Life Sciences Int’l., (Holdings) Inc. (“the Company”) announced that the Company will be presenting new data from its cancer vaccine research pipeline at the 2025 American Association ...

Qiyong Liu and colleagues consider the experience of basic malaria elimination, resurgence, and re-elimination in the Huai River Basin in central China, as well as lessons learnt to help to inform ...